Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivo
- Autores
- Loos, Julia Alexandra; Negro, Perla; Salerno, Graciela Lidia; Cumino, Andrea Carina
- Año de publicación
- 2022
- Idioma
- inglés
- Tipo de recurso
- documento de conferencia
- Estado
- versión publicada
- Descripción
- Cystic echinococcosis is a progressive and chronic disease caused by the larval stage of the species complex Echinococcus granulosus sensu latu. New treatment options are needed especially for advanced disease. Since in these cestodes glycogen is the main energy storage molecule and glucose the major fermentative substrate, our approach was to target the metabolic pathways of the parasite involved in energy production, focusing on the AMPK/TOR pathway. Here, the aim was to assess the in vivo efficacy of metformin as an indirect AMPK agonist, in an advanced disease model (1year post-infection in mice), employing the highest dose of assayed drug (250 mg kg−1 day−1). Metformin-treated mice exhibited a reduction of cellular integrity of the germinal layer of cysts, registering a drug concentration of 1.7 mM (which inhibits mitochondrial respiratory chain complex I), a reduction in intracystic glucose with an increase in lactate concentration, consistent with the rise in the glycogen breakdown and in the LDH activity. Interestingly, the fraction of reducing soluble sugars decreased by 3 times in the cystic fluid and germinal cells after of drug-treatment. However, non-reducing soluble sugars, such as sucrose and trehalose, were consumed in the cystic fluid but showed a significant increase at the intracellular level in presence of the drug. It is surprising that trehalose and sucrose biosynthesis was upregulated during starvation induced by metformin. That is, a futile cycle of non-reducing sugars synthesis and glycogen catabolism during starvation. Function of these disaccharides as stress protectants during starvation provides some resolution to this paradox, as it also occurs in others invertebrates and plants. In the same line evidence, fasting and starvation induce hepatic gluconeogenesis in mammalians. Thus, in this parasite metformin affects glucose-starvation-induced AMPK activation and restructures carbohydrate metabolism prior induction of cell death.
Fil: Loos, Julia Alexandra. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
Fil: Negro, Perla. Universidad Nacional de Rosario. Facultad de Ciencias Veterinarias; Argentina
Fil: Salerno, Graciela Lidia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mar del Plata. Instituto de Investigaciones en Biodiversidad y Biotecnología; Argentina
Fil: Cumino, Andrea Carina. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
LXVII Reunión Anual de la Sociedad Argentina de Investigación Clínica; LXX Reunión Anual de la Sociedad Argentina de Inmunología & 3er Congreso Franco Argentino de Inmunología y Reunión Anual 2022 de la Sociedad Argentina de Fisiología
Mar del Plata
Argentina
Sociedad Argentina de Investigación Clínica
Sociedad Argentina de Inmunología
Sociedad Argentina de Fisiología - Materia
-
ECHINOCOCCUS SP
INTERMEDIARY CARBON METABOLISM
METFORMIN
IN VIVO TREATMENT - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/234238
Ver los metadatos del registro completo
| id |
CONICETDig_8a4db1b8f74a8465f857ed5d3792ca4e |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/234238 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivoLoos, Julia AlexandraNegro, PerlaSalerno, Graciela LidiaCumino, Andrea CarinaECHINOCOCCUS SPINTERMEDIARY CARBON METABOLISMMETFORMININ VIVO TREATMENThttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Cystic echinococcosis is a progressive and chronic disease caused by the larval stage of the species complex Echinococcus granulosus sensu latu. New treatment options are needed especially for advanced disease. Since in these cestodes glycogen is the main energy storage molecule and glucose the major fermentative substrate, our approach was to target the metabolic pathways of the parasite involved in energy production, focusing on the AMPK/TOR pathway. Here, the aim was to assess the in vivo efficacy of metformin as an indirect AMPK agonist, in an advanced disease model (1year post-infection in mice), employing the highest dose of assayed drug (250 mg kg−1 day−1). Metformin-treated mice exhibited a reduction of cellular integrity of the germinal layer of cysts, registering a drug concentration of 1.7 mM (which inhibits mitochondrial respiratory chain complex I), a reduction in intracystic glucose with an increase in lactate concentration, consistent with the rise in the glycogen breakdown and in the LDH activity. Interestingly, the fraction of reducing soluble sugars decreased by 3 times in the cystic fluid and germinal cells after of drug-treatment. However, non-reducing soluble sugars, such as sucrose and trehalose, were consumed in the cystic fluid but showed a significant increase at the intracellular level in presence of the drug. It is surprising that trehalose and sucrose biosynthesis was upregulated during starvation induced by metformin. That is, a futile cycle of non-reducing sugars synthesis and glycogen catabolism during starvation. Function of these disaccharides as stress protectants during starvation provides some resolution to this paradox, as it also occurs in others invertebrates and plants. In the same line evidence, fasting and starvation induce hepatic gluconeogenesis in mammalians. Thus, in this parasite metformin affects glucose-starvation-induced AMPK activation and restructures carbohydrate metabolism prior induction of cell death.Fil: Loos, Julia Alexandra. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; ArgentinaFil: Negro, Perla. Universidad Nacional de Rosario. Facultad de Ciencias Veterinarias; ArgentinaFil: Salerno, Graciela Lidia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mar del Plata. Instituto de Investigaciones en Biodiversidad y Biotecnología; ArgentinaFil: Cumino, Andrea Carina. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; ArgentinaLXVII Reunión Anual de la Sociedad Argentina de Investigación Clínica; LXX Reunión Anual de la Sociedad Argentina de Inmunología & 3er Congreso Franco Argentino de Inmunología y Reunión Anual 2022 de la Sociedad Argentina de FisiologíaMar del PlataArgentinaSociedad Argentina de Investigación ClínicaSociedad Argentina de InmunologíaSociedad Argentina de FisiologíaFundación Revista Medicina2022info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/234238Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivo; LXVII Reunión Anual de la Sociedad Argentina de Investigación Clínica; LXX Reunión Anual de la Sociedad Argentina de Inmunología & 3er Congreso Franco Argentino de Inmunología y Reunión Anual 2022 de la Sociedad Argentina de Fisiología; Mar del Plata; Argentina; 2022; 1-31669-9106CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.medicinabuenosaires.com/revistas/vol82-22/s5/1s5.pdfNacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T12:02:48Zoai:ri.conicet.gov.ar:11336/234238instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 12:02:48.991CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivo |
| title |
Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivo |
| spellingShingle |
Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivo Loos, Julia Alexandra ECHINOCOCCUS SP INTERMEDIARY CARBON METABOLISM METFORMIN IN VIVO TREATMENT |
| title_short |
Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivo |
| title_full |
Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivo |
| title_fullStr |
Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivo |
| title_full_unstemmed |
Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivo |
| title_sort |
Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivo |
| dc.creator.none.fl_str_mv |
Loos, Julia Alexandra Negro, Perla Salerno, Graciela Lidia Cumino, Andrea Carina |
| author |
Loos, Julia Alexandra |
| author_facet |
Loos, Julia Alexandra Negro, Perla Salerno, Graciela Lidia Cumino, Andrea Carina |
| author_role |
author |
| author2 |
Negro, Perla Salerno, Graciela Lidia Cumino, Andrea Carina |
| author2_role |
author author author |
| dc.subject.none.fl_str_mv |
ECHINOCOCCUS SP INTERMEDIARY CARBON METABOLISM METFORMIN IN VIVO TREATMENT |
| topic |
ECHINOCOCCUS SP INTERMEDIARY CARBON METABOLISM METFORMIN IN VIVO TREATMENT |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
| dc.description.none.fl_txt_mv |
Cystic echinococcosis is a progressive and chronic disease caused by the larval stage of the species complex Echinococcus granulosus sensu latu. New treatment options are needed especially for advanced disease. Since in these cestodes glycogen is the main energy storage molecule and glucose the major fermentative substrate, our approach was to target the metabolic pathways of the parasite involved in energy production, focusing on the AMPK/TOR pathway. Here, the aim was to assess the in vivo efficacy of metformin as an indirect AMPK agonist, in an advanced disease model (1year post-infection in mice), employing the highest dose of assayed drug (250 mg kg−1 day−1). Metformin-treated mice exhibited a reduction of cellular integrity of the germinal layer of cysts, registering a drug concentration of 1.7 mM (which inhibits mitochondrial respiratory chain complex I), a reduction in intracystic glucose with an increase in lactate concentration, consistent with the rise in the glycogen breakdown and in the LDH activity. Interestingly, the fraction of reducing soluble sugars decreased by 3 times in the cystic fluid and germinal cells after of drug-treatment. However, non-reducing soluble sugars, such as sucrose and trehalose, were consumed in the cystic fluid but showed a significant increase at the intracellular level in presence of the drug. It is surprising that trehalose and sucrose biosynthesis was upregulated during starvation induced by metformin. That is, a futile cycle of non-reducing sugars synthesis and glycogen catabolism during starvation. Function of these disaccharides as stress protectants during starvation provides some resolution to this paradox, as it also occurs in others invertebrates and plants. In the same line evidence, fasting and starvation induce hepatic gluconeogenesis in mammalians. Thus, in this parasite metformin affects glucose-starvation-induced AMPK activation and restructures carbohydrate metabolism prior induction of cell death. Fil: Loos, Julia Alexandra. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina Fil: Negro, Perla. Universidad Nacional de Rosario. Facultad de Ciencias Veterinarias; Argentina Fil: Salerno, Graciela Lidia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mar del Plata. Instituto de Investigaciones en Biodiversidad y Biotecnología; Argentina Fil: Cumino, Andrea Carina. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina LXVII Reunión Anual de la Sociedad Argentina de Investigación Clínica; LXX Reunión Anual de la Sociedad Argentina de Inmunología & 3er Congreso Franco Argentino de Inmunología y Reunión Anual 2022 de la Sociedad Argentina de Fisiología Mar del Plata Argentina Sociedad Argentina de Investigación Clínica Sociedad Argentina de Inmunología Sociedad Argentina de Fisiología |
| description |
Cystic echinococcosis is a progressive and chronic disease caused by the larval stage of the species complex Echinococcus granulosus sensu latu. New treatment options are needed especially for advanced disease. Since in these cestodes glycogen is the main energy storage molecule and glucose the major fermentative substrate, our approach was to target the metabolic pathways of the parasite involved in energy production, focusing on the AMPK/TOR pathway. Here, the aim was to assess the in vivo efficacy of metformin as an indirect AMPK agonist, in an advanced disease model (1year post-infection in mice), employing the highest dose of assayed drug (250 mg kg−1 day−1). Metformin-treated mice exhibited a reduction of cellular integrity of the germinal layer of cysts, registering a drug concentration of 1.7 mM (which inhibits mitochondrial respiratory chain complex I), a reduction in intracystic glucose with an increase in lactate concentration, consistent with the rise in the glycogen breakdown and in the LDH activity. Interestingly, the fraction of reducing soluble sugars decreased by 3 times in the cystic fluid and germinal cells after of drug-treatment. However, non-reducing soluble sugars, such as sucrose and trehalose, were consumed in the cystic fluid but showed a significant increase at the intracellular level in presence of the drug. It is surprising that trehalose and sucrose biosynthesis was upregulated during starvation induced by metformin. That is, a futile cycle of non-reducing sugars synthesis and glycogen catabolism during starvation. Function of these disaccharides as stress protectants during starvation provides some resolution to this paradox, as it also occurs in others invertebrates and plants. In the same line evidence, fasting and starvation induce hepatic gluconeogenesis in mammalians. Thus, in this parasite metformin affects glucose-starvation-induced AMPK activation and restructures carbohydrate metabolism prior induction of cell death. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/conferenceObject Reunión Journal http://purl.org/coar/resource_type/c_5794 info:ar-repo/semantics/documentoDeConferencia |
| status_str |
publishedVersion |
| format |
conferenceObject |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/234238 Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivo; LXVII Reunión Anual de la Sociedad Argentina de Investigación Clínica; LXX Reunión Anual de la Sociedad Argentina de Inmunología & 3er Congreso Franco Argentino de Inmunología y Reunión Anual 2022 de la Sociedad Argentina de Fisiología; Mar del Plata; Argentina; 2022; 1-3 1669-9106 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/234238 |
| identifier_str_mv |
Advanced experimental cystic echinococcosis: reprogramming of the intermediary carbon metabolism in the parasite under metformin treatment in vivo; LXVII Reunión Anual de la Sociedad Argentina de Investigación Clínica; LXX Reunión Anual de la Sociedad Argentina de Inmunología & 3er Congreso Franco Argentino de Inmunología y Reunión Anual 2022 de la Sociedad Argentina de Fisiología; Mar del Plata; Argentina; 2022; 1-3 1669-9106 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.medicinabuenosaires.com/revistas/vol82-22/s5/1s5.pdf |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
| dc.coverage.none.fl_str_mv |
Nacional |
| dc.publisher.none.fl_str_mv |
Fundación Revista Medicina |
| publisher.none.fl_str_mv |
Fundación Revista Medicina |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1846782366643650560 |
| score |
12.982451 |